ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $656,000 | -12.4% | 34,774 | -45.4% | 0.00% | – |
| Q2 2019 | $749,000 | -17.5% | 63,695 | -4.2% | 0.00% | – |
| Q1 2019 | $908,000 | +37.0% | 66,505 | +2.7% | 0.00% | – |
| Q4 2018 | $663,000 | -13.0% | 64,732 | +41.4% | 0.00% | – |
| Q3 2018 | $762,000 | +27.4% | 45,782 | +20.7% | 0.00% | – |
| Q2 2018 | $598,000 | -17.1% | 37,935 | -33.2% | 0.00% | – |
| Q1 2018 | $721,000 | +86.8% | 56,810 | +68.6% | 0.00% | – |
| Q4 2017 | $386,000 | +247.7% | 33,689 | +271.2% | 0.00% | – |
| Q3 2017 | $111,000 | +296.4% | 9,075 | +274.1% | 0.00% | – |
| Q2 2017 | $28,000 | -99.3% | 2,426 | -98.7% | 0.00% | -100.0% |
| Q1 2017 | $3,958,000 | -8.0% | 190,253 | -8.0% | 0.00% | 0.0% |
| Q4 2016 | $4,304,000 | -33.1% | 206,897 | +5.4% | 0.00% | -50.0% |
| Q3 2016 | $6,434,000 | +51.3% | 196,334 | +15.3% | 0.00% | +33.3% |
| Q2 2016 | $4,253,000 | +141666.7% | 170,354 | +159109.3% | 0.00% | – |
| Q4 2015 | $3,000 | -93.8% | 107 | -92.7% | 0.00% | – |
| Q3 2015 | $48,000 | -76.0% | 1,463 | -61.3% | 0.00% | – |
| Q2 2015 | $200,000 | -14.5% | 3,779 | -53.5% | 0.00% | – |
| Q1 2015 | $234,000 | -46.6% | 8,132 | -45.9% | 0.00% | – |
| Q4 2014 | $438,000 | +69.8% | 15,045 | -26.0% | 0.00% | – |
| Q3 2014 | $258,000 | -30.6% | 20,322 | +9.7% | 0.00% | – |
| Q2 2014 | $372,000 | – | 18,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |